May 2 |
Puma Biotechnology Reports First Quarter Financial Results
|
May 1 |
Puma Biotechnology Q1 2024 Earnings Preview
|
Apr 29 |
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
|
Apr 26 |
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
|
Apr 18 |
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
|
Apr 8 |
Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
|
Mar 22 |
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
|
Mar 22 |
Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
|
Mar 20 |
Puma Biotech cleared to trial Takeda-partnered breast cancer therapy in U.S.
|
Mar 20 |
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
|